RxDoctor Payments Data

Benjamin Freedman

Cardiovascular Disease · Boston, MANPI 1689168312

Payments from drug & device makers

$3,734in general payments, 2019–2025

Across 70 payments — averaging $53.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$2K
  • AstraZeneca$292
  • Amgen$283
  • Pfizer$214
  • Alnylam Pharmaceuticals Inc.$189
  • Boehringer Ingelheim$114
  • plus $760 from 15 others

What the payments were for

  • Travel & lodging$1,88150%
  • Food & beverage$1,85250%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,734 in reported general payments places this provider in the 55th percentile of 750 cardiovascular disease providers in Massachusetts.

See all cardiovascular disease providers in Massachusetts

Most prescribed under Part D

DrugClaimsCost to plans & patients
Colchicine12$717
Atorvastatin Calcium15$189
Metoprolol Succinate14$166

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →